Prophylactic nirsevimab protects infants from respiratory syncytial virus infection
1. Single-dose intramuscular injection of nirsevimab significantly reduced respiratory syncytial virus (RSV) infection in infants. 2. Nirsevimab was shown to ...
1. Single-dose intramuscular injection of nirsevimab significantly reduced respiratory syncytial virus (RSV) infection in infants. 2. Nirsevimab was shown to ...
1. About 1 in 25 children younger than age 15 years died within 90 days of hospital discharge in Southern ...
Hospitalized pediatric patients who used videoconferencing equipment to communicate with family and friends experienced a 37% reduction in overall stress, ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.